Perturbation of cellular calcium delays the secretion and alters the glycosylation of thyroglobulin in FRTL-5 cells

Biochem Biophys Res Commun. 1997 May 8;234(1):133-6. doi: 10.1006/bbrc.1997.6601.

Abstract

Treatment of FRTL-5 cells with a Ca2+ ionophore, A23187, or a specific inhibitor of the endoplasmic reticulum Ca2+ ATPases, thapsigargin, delayed thyroglobulin secretion. The secreted thyroglobulin showed an increased electrophoretic mobility and a reduced sensitivity to neuraminidase. Only thyroglobulin that was still in the endoplasmic reticulum was sensitive to the Ca(2+)-perturbant drugs as shown by experiments in which the drugs were added at different times during a chase. Analysis of the carbohydrate chains by BioGel P4 showed that thyroglobulin secreted in the presence of the Ca(2+)-perturbants displayed an increased ratio high mannose/complex chains.

MeSH terms

  • Animals
  • Calcimycin / pharmacology
  • Calcium / metabolism*
  • Cell Line
  • Chromatography, Gel
  • Electrophoresis, Polyacrylamide Gel
  • Endoplasmic Reticulum / metabolism
  • Enzyme Inhibitors / pharmacology
  • Glycosylation
  • Hexosaminidases / metabolism
  • Ionophores / pharmacology
  • Mannose / analysis
  • N-Acetylneuraminic Acid
  • Neuraminidase / metabolism
  • Precipitin Tests
  • Pronase / metabolism
  • Rats
  • Thapsigargin / pharmacology
  • Thyroglobulin / chemistry
  • Thyroglobulin / metabolism*

Substances

  • Enzyme Inhibitors
  • Ionophores
  • Calcimycin
  • Thapsigargin
  • Thyroglobulin
  • Hexosaminidases
  • Neuraminidase
  • Pronase
  • N-Acetylneuraminic Acid
  • Mannose
  • Calcium